Optical coherence tomography: Clinical applications and the evaluation of DES

Minerva Cardioangiologica

Volumn 56, Issue 5, 2008, Pages 511-525

  Gonzalo, N ^a   Serruys, P W ^a   Regar, E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Coronary artery disease; Drug eluting stents; Tomography, optical coherence

Indexed keywords

EVEROLIMUS; PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS;

ARTERY INTIMA PROLIFERATION; ATHEROMA; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG ELUTING STENT; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE QUALITY; INTRAVASCULAR ULTRASOUND; MACROPHAGE; OPTICAL COHERENCE TOMOGRAPHY; REVIEW; THICKNESS;

CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; HUMANS; MONITORING, INTRAOPERATIVE; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 55749108190     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Di Mario C, Gorge G, Peters R, Kearney P, Pinto F, Hausmann D et al. Clinical application and image interpretation in intracoronary ultrasound. Study Group on Intracoronary Imaging of the Working Group of Coronary Circulation and of the Subgroup on Intravascular Ultrasound of the Working Group of Echocardiography of the European Society of Cardiology. Eur Heart J 1998;19(2):207-29.
2. Mintz GS, Nissen S. E, Anderson W. D, Bailey S. R, Erbel R, Fitzgerald P. J, et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001;37(5):1478-92.
3. Boppart SA, Bouma BE, Pitris C, Southern JF, Brezinski ME, Fujimoto JG. In vivo cellular optical coherence tomography imaging. Nat Med 1998;4:861-5.
4. Regar E, Schaar J, Mont E, Virmani R, Serruys PW. Optical coherence tomography. Cardiovasc Rad Med 2003;4:198-204.
5. Regar E vLA, Serruys PW, editors. Optical Coherence Tomography in cardiovascular research. London: Informa Healthcare; 2007.
6. Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W et al. Optical coherence tomography. Science 1991;254:1178-81.
7. Huang D, Wang J, Lin CP, Puliafito CA, Fujimoto JG. Micron-resolution ranging of cornea anterior chamber by optical reflectometry. Lasers Surg Med 1991;11:419-25.
8. Panozzo G, Gusson E, Parolini B, Mercanti A. Role of OCT in the diagnosis and follow up of diabetic macular edema. Semin Ophthalmol 2003;18:74-81.
9. Li XD, Boppart SA, Van Dam J, Mashimo H, Mutinga M, Drexler W et al. Optical coherence tomography: advanced technology for the endoscopic imaging of Barrett's esophagus. Endoscopy 2000;32:921-30.
10. Tearney GJ, Brezinski ME, Southern JF, Bouma BE, Boppart SA, Fujimoto JG. Optical biopsy in human urologic tissue using optical coherence tomography. J Urol 1997;157:1915-9.
11. Welzel J, Lankenau E, Birngruber R, Engelhardt R. Optical coherence tomography of the human skin. J Am Acad Dermatol 1997;37:958-63.
12. Tearney GJ, Brezinski ME, Boppart SA, Bouma BE, Weissman N, Southern JF et al. Images in cardiovascular medicine. Catheter-based optical imaging of a human coronary artery. Circulation 1996;94:3013.
13. Brezinski ME, Tearney GJ, Bouma BE, Boppart SA, Hee MR, Swanson EA et al. Imaging of coronary artery microstructure (in vitro) with optical coherence tomography. Am J Cardiol 1996;77:92-3.
14. Tearney GJ, Jang IK, Kang DH, Aretz HT, Houser SL, Brady TJ et al. Porcine coronary imaging in vivo by optical coherence tomography. Acta Cardiol 2000;55:233-7.
15. Fujimoto JG, Boppart SA, Tearney GJ, Bouma BE, Pitris C, Brezinski ME. High resolution in vivo intra-arterial imaging with optical coherence tomography. Heart 1999;82:128-33.
16. Jang IK, Bouma BE, Kang DH, Park SJ, Park SW, Seung KB et al. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol 2002;39:604-9.
17. Yun SH, Tearney GJ, Vakoc BJ, Shisnkov M, Oh WY, Desjardins AE et al. Comprehensive volumetric optical microscopy in vivo. Nat Med 2006;12:1429-33.
18. Liu B, Brezinski ME. Theoretical and practical considerations on detection performance of time domain, Fourier domain, and swept source optical coherence tomography. J Biomed Opt 2007;12:044007.
19. Asawa K, Kataoka T, Kobayashi Y, Hasegawa T, Nishioka H, Yamashita H et al. Method analysis for optimal continuous imaging using intravascular optical coherence tomography. J Cardiol 2006;47:133-41.
20. Prati F CM, Ramazzotti V, Imola F, Giudice R, Albertucci M. Safety and feasibility of a new non-occlusive technique for facilitated intracoronary optical coherence tomography(OCT) acquisition in various clinical and anatomical scenarios. Eurointervention 2007;3:365-70.
21. Prati F, Cera M, Ramazzotti V, Imola F, Giudice R, Giudice M et al. From bench to bedside. Circ J 2008;72:839-43.
22. Gonzalo N, Regar Evelyn. Tips and tricks for intravascular optical coherence tomography. In: Sabate editor. Percutaneous Interventions beyond stenting. Tips and tricks for new technology. Informa Healthcare. In press.
23. Yamaguchi T, Terashima M, Akasaka T, Hayashi T, Mizuno K, Muramatsu T et al. Safety and feasibility of an intravascular optical coherence tomography image wire system in the clinical setting. Am J Cardiol 2008;101:562-7.
24. van Beusekom HMM, Regar E, Peters, van der Giessen WJ. Assessment of long-term radiation effects following balloon angioplasty by OCT imaging and histology. In. London: Informa Healthcare; 2007.
25. Aoki J, Colombo A, Dudek D, Banning AP, Drzewiecki J, Zmudka K et al. Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study. Circulation 2005;112:3876-83.
26. Grube E, Gerckens U, Buellesfeld L, Fitzgerald PJ. Images in cardiovascular medicine. Intracoronary imaging with optical coherence tomography: a new high-resolution technology providing striking visualization in the coronary artery. Circulation 2002;106:2409-10.
27. Bouma BE, Tearney GJ, Yabushita H, Shishkov M, Kauffman CR, DeJoseph Gauthier D et al. Evaluation of intracoronary stenting by intravascular optical coherence tomography. Heart 2003;89:317-20.
28. Tanigawa J BP, Dimopoulos K, Di Mario C. Optical coherence tomography to assess malapposition in overlapping drug-eluting stents. Eurointervention 2008;3:580-3.
29. Tanigawa J, Barlis P, Di Mario C. Heavily calcified coronary lesions preclude strut apposition despite high pressure balloon dilatation and rotational atherectomy: in-vivo demonstration with optical coherence tomography. Circ J 2008;72:157-60.
30. Alfonso F, Suarez A, Perez-Vizcayno MJ, Moreno R, Escaned J, Banuelos C et al. Intravascular ultrasound findings during episodes of drug-eluting stent thrombosis. J Am Coll Cardiol 2007;50:2095-7.
31. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007;115:2426-34.
32. Peres F, Costa JR, Jr., Abizaid A. Very late thrombosis after drug-eluting stents. Catheter Cardiovasc Interv 2006;68:83-8.
33. Xie Y, Takano M, Murakami D, Yamamoto M, Okamatsu K, Inami S et al. Comparison of neointimal coverage by optical coherence tomography of a sirolimus-eluting stent versus a bare-metal stent three months after implantation. Am J Cardiol 2008;102:27-31.
34. Barlis P, Di Mario C, van Beusekom HMM, Gonzalo N, Regar E. Novelties in Cardiac Imaging - Optical Coherence Tomography (OCT). A critical appraisal of the safety concerns tempering the success of drug-eluting stents. Eurointervention 2008; In press.
35. Schinkel AFL vBH, Maugenest AM; van Wunnik S, Serruys PW, Regar E. OCT Findings in very late (4 y years) paclitaxel-eluting stent thrombosis. J Am Coll Cardiol Interventions 2008; In press.
36. Regar E, Schaar J, Serruys PW. Images in cardiology. Acute recoil in sirolimus eluting stent: real time, in vivo assessment with optical coherence tomography. Heart 2006;92:123.
37. Schwarzacher SP, Metz JA, Yock PG, Fitzgerald PJ. Vessel tearing at the edge of intracoronary stents detected with intravascular ultrasound imaging. Cathet Cardiovasc Diagn 1997;40:152-5.
38. Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992;19:267-74.
39. Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999;99:44-52.
40. Schroeder S, Baumbach A, Mahrholdt H, Haase KK, Oberhoff M, Herdeg C et al. The impact of untreated coronary dissections on acute and long-term outcome after intravascular ultrasound guided PTCA. Eur Heart J 2000;21:137-45.
41. Hong MK, Park SW, Lee NH, Nah DY, Lee CW, Kang DH et al. Long-term outcomes of minor dissection at the edge of stents detected with intravascular ultrasound. Am J Cardiol 2000;86:791-5, A9.
42. Nishida T, Colombo A, Briguori C, Stankovic G, Albiero R, Corvaja N et al. Outcome of nonobstructive residual dissections detected by intravascular ultrasound following percutaneous coronary intervention. Am J Cardiol 2002;89:1257-62.
43. Jang IK, Tearney G, Bouma B. Visualization of tissue prolapse between coronary stent struts by optical coherence tomography: comparison with intravascular ultrasound. Circulation 2001;104:2754.
44. Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003;108:1701-6.
45. Futamatsu H, Sabate M, Angiolillo DJ, Jimenez-Quevedo P, Corros C, Morikawa-Futamatsu K et al. Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three-dimensional volumetric intravascular ultrasound outcome study. J Am Coll Cardiol 2006;48:1139-45.
46. Sawada T, Shite J, Shinke T, Watanabe S, Otake H, Matsumoto D et al. Persistent malapposition after implantation of sirolimus-eluting stent into intramural coronary hematoma: optical coherence tomography observations. Circ J 2006;70:x1515-9.
47. Chen BX, Ma FY, Luo W, Ruan JH, Xie WL, Zhao XZ et al. Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography. Heart 2008;94:566-70.
48. Matsumoto D, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J 2007;28:961-7.
49. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 2007;115:2435-41.
50. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
51. Awata M, Kotani J, Uematsu M, Morozumi T, Watanabe T, Onishi T et al. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents. Circulation 2007;116:910-6.
52. Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 2006;47:2108-11.
53. Serruys PW, Degertekin M, Tanabe K, Abizaid A, Sousa JE, Colombo A et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 2002;106:798-803.
54. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350(3):221-31.
55. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.
56. Gerckens U, Lim VY, Grube E. Optical coherence tomography imaging in coronary drug-eluting stenting. Rev Esp Cardiol 2005;58:1469.
57. Takano M, Jang IK, Mizuno K. Neointimal proliferation around malapposed struts of a sirolimus-eluting stent: optical coherence tomography findings. Eur Heart J 2006;27:1763.
58. Prati F, Zimarino M, Stabile E, Pizzicannella G, Fouad T, Rabozzi R et al. Does optical coherence tomography identify arterial healing after stenting? An in vivo comparison with histology, in a rabbit carotid model. Heart 2008;94:217-21.
59. Tanimoto S, Rodriguez-Granillo G, Barlis P, de Winter S, Bruining N, Hamers et al. A novel approach for quantitative analysis of intracoronary optical coherence tomography. High inter-observer agreement with computer-assisted contour detection. Catheter Cardiovasc Interv 2008;6:Epub ahead of print.
60. Yao ZH, Matsubara T, Inada T, Suzuki Y, Suzuki T. Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography. Chin Med J (Engl) 2008;121:503-7.
61. Takano M, Yamamoto M, Inami S, Murakami D, Seimiya K, Ohba T et al. Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist? J Am Coll Cardiol 2008;51:968-9.
62. Regar E, van Beusekom HMM, van der Giessen WJ, Serruys PW. Optical coherence tomography findings at 5-year follow-up after coronary stent implantation. Circulation 2005;112:345-6.
63. Takano M, Xie Y, Murakami D, Inami S, Yamamoto M, Ohba T et al. Various optical coherence tomographic findings in restenotic lesions after sirolimus-eluting stent implantation. Int J Cardiol 2008. In press.
64. Tanimoto S AJ, Serruys PW, Regar E. Paclitaxel-eluting stent restenosis shows three - layer appearance by optical coherence tomography. Eurointervention 2006;1(484).
65. Grube E, Lim V, Buellesfeld L. OCT findings in drug-eluting stents. In: Regar E, van Leeuwen T, Serruys P.W Editors. Optical coherence tomography in cardiovascular research. London: Informa Healthcare; 2007.
66. Shite J, Matsumoto D, Yokoyama M. Sirolimus-eluting stent fracture with thrombus, visualization by optical coherence tomography. Eur Heart J 2006;27:1389.
67. Schulz C, Herrmann RA, Beilharz C, Pasquantonio J, Alt E. Coronary stent symmetry and vascular injury determine experimental restenosis. Heart 2000;83:462-7.
68. Takebayashi H, Mintz GS, Carlier SG, Kobayashi Y, Fujii K, Yasuda T et al. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation. Circulation 2004;110:3430-4.
69. Suzuki Y, Ikeno F, Yeung AC. Drug-eluting stent strut distribution: a comparison between Cypher and Taxus by optical coherence tomography. J Invasive Cardiol 2006;18:111-4.
70. Buellesfeld L, Lim V, Gerckens U, Mueller R, Grube E. Comparative endoluminal visualization of TAXUS crush-stenting at 9 months follow-up by intravascular ultrasound and optical coherence tomography. Z Kardiol 2005;94:690-4.
71. Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single denovo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet 2008;371:899-907.
72. Garcia-Garcia HM, Gonzalo N, Regar E, Serruys PW. Diagnosis and treatment of vulnerable plaque. Expert Rev Cardiovasc Ther 2008;6:209-22.
73. Serruys PW, Garcia-Garcia HM, Regar E. From postmortem characterization to the in-vivo detection of thin-capped fibroatheromas: the missing link towards percutaneous treatment. J Am Coll Cardiol 2007;50:950-2.
74. Yabushita H, Bouma BE, Houser SL, Aretz HT, Jang IK, Schiendorf KH et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002;106:1640-5.
75. Rieber J, Meissner O, Babaryka G, Reim S, Oswald M, Koenig A et al. Diagnostic accuracy of optical coherence tomography and intravascular ultrasound for the detection and characterization of atherosclerotic plaque composition in ex-vivo coronary specimens: a comparison with histology. Coron Artery Dis 2006;17:425-30.
76. Patwari P, Weissman NJ, Boppart SA, Jesser C, Stamper D, Fujimoto JG et al. Assessment of coronary plaque with optical coherence tomography and high-frequency ultrasound. Am J Cardiol 2000;85:641-4.
77. Kawasaki M, Bouma BE, Bressner J, Houser SL, Nadkarni SK, MacNeill BD et al. Diagnostic accuracy of optical coherence tomography and integrated back-scatter intravascular ultrasound images for tissue characterization of human coronary plaques. J Am Coll Cardiol 2006;48:81-8.
78. Kume T, Akasaka T, Kawamoto T, Watanabe N, Toyota E, Neishi Y et al. Assessment of coronary arterial plaque by optical coherence tomography. Am J Cardiol 2006;97:1172-5.
79. Jang IK, Teamey GJ, MacNeill B, Takano M, Moselewski F, Iftima N et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 2005;111:1551-5.
80. Chia S, Raffel OC, Takano M, Tearney GJ, Bouma BE, Jang IK. Comparison of coronary plaque characteristics between diabetic and non-diabetic subjects: An in vivo optical coherence tomography study. Diabetes Res Clin Pract 2008. In press.
81. Chia S, Christopher Raffel O, Takano M, Tearney GJ, Bouma BE, Jang IK. In-vivo comparison of coronary plaque characteristics using optical coherence tomography in women vs. men with acute coronary syndrome. Coron Artery Dis 2007;18:423-7.
82. Kume T, Okura H, Kawamoto T, Akasaka T, Toyota E, Watanabe N et al. Relationship between coronary remodeling and plaque characterization in patients without clinical evidence of coronary artery disease. Atherosclerosis 2008;197:799-805.
83. Meng L, Lv B, Zhang S, Yv B. In vivo optical coherence tomography of experimental thrombosis in a rabbit carotid model. Heart 2008;94:777-80.
84. Barlis P, Serruys PW, de Vries A, Regar E. Optical coherence tomography assessment of vulnerable plaque rupture: Predilection for the plaque 'shoulder'. Eur Heart J 2008 [Epub ahead of print].
85. Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol 2007;50:933-9.
86. Kume T, Akasaka T, Kawamoto T, Ogasawara Y, Watanabe N, Toyota E et al. Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol 2006;97:1713-7.
87. Kume T, Akasaka T, Kawamoto T, Okura H, Watanabe N, Toyota E et al. Measurement of the thickness of the fibrous cap by optical coherence tomography. Am Heart J 2006;152:755 e1-4.
88. Cilingiroglu M, OhJH, Sugunan B, Kemp NJ, Kim J, Lee S et al. Detection of vulnerable plaque in a murine model of atherosclerosis with optical coherence tomography. Catheter Cardiovasc Interv 2006;67:915-23.
89. Barlis P, Serruys PW, Gonzalo N, Van der Giessen W, Jaegere PJ, Regar E. Assessment of culprit and remote coronary narrowings using optical coherence tomography with long-term outcomes. Am J Cardiol 2008. In press.
90. Kubo TIT, Takarada S, Kuroi A, Ueno S, Yamano T, Tanimoto T et al. Implication of plaque color classification for assessing plaque vulnerability. J Am Coll Cardiol Intv 2008;1:74-80.
91. Takano M, Jang IK, Inami S, Yamamoto M, Murakami D, Okamatsu K et al. In vivo comparison of optical coherence tomography and angioscopy for the evaluation of coronary plaque characteristics. Am J Cardiol 2008;101:471-6.
92. Chia S, Raffel OC, Takano M, Tearney GJ, Bouma BE, Jang IK. Association of statin therapy with reduced coronary plaque rupture: an optical coherence tomography study. Coron Artery Dis 2008;19:237-42.
93. Takarada S, Imanishi T, Kubo T, Tanimoto T, Kitabata H, Nakamura N et al. Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: Assessment by optical coherence tomography study. Atherosclerosis 2008. In press.
94. Nadkarni SK, Pierce MC, Park BH, de Boer JF, Whittaker P, Bouma BE et al. Measurement of collagen and smooth muscle cell content in atherosclerotic plaques using polarization-sensitive optical coherence tomography. J Am Coll Cardiol 2007;49:1474-81.
95. Tearney GJ, Yabushita H, Houser SL, Aretz HT, Jang IK, Schlendorf KH et al. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation 2003;107:113-9.
96. MacNeill BD, Jang IK, Bouma BE, Iftimia N, Takano M, Yabushita H et al. Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. J Am Coll Cardiol 2004;44:972-9.
97. Raffel OC, Tearney GJ, Gauthier DD, Halpern EF, Bouma BE, Jang IK. Relationship between a systemic inflammatory marker, plaque inflammation, and plaque characteristics determined by intravascular optical coherence tomography. Arterioscler Thromb Vasc Biol 2007;27:1820-7.
98. Manfrini O, Mont E, Leone O, Arbustini E, Eusebi V, Virmani R et al. Sources of error and interpretation of plaque morphology by optical coherence tomography. Am J Cardiol 2006;98:156-9.
99. Sawada T, Shite J, Garcia-Garcia HM, Shinke T, Watanabe S, Otake H et al. Feasibility of combined use of intravascular ultrasound radiofrequency data analysis and optical coherence tomography for detecting thin-cap flbroatheroma. Eur Heart J 2008;29:1136-46.